Update of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population

dc.contributor.authorFabián Juliao Baños
dc.contributor.authorCarlos Fernando Grillo‐Ardila
dc.contributor.authorIgnacio Alfaro
dc.contributor.authorM.T. Andara-Ramírez
dc.contributor.authorO. Avelar-Escobar
dc.contributor.authorJ. Barahona-Garrido
dc.contributor.authorS. Bautista-Martínez
dc.contributor.authorFrancisco Bosques‐Padilla
dc.contributor.authorJuan A. De Paula
dc.contributor.authorKenneth Ernest-Suárez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:03:44Z
dc.date.available2026-03-22T21:03:44Z
dc.date.issued2022
dc.descriptionCitaciones: 10
dc.identifier.doi10.1016/j.rgmxen.2022.04.006
dc.identifier.urihttps://doi.org/10.1016/j.rgmxen.2022.04.006
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85701
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofRevista de Gastroenterología de México (English Edition)
dc.sourceHospital Pablo Tobon Uribe
dc.subjectMedicine
dc.subjectTofacitinib
dc.subjectUlcerative colitis
dc.subjectPouchitis
dc.subjectVedolizumab
dc.subjectUstekinumab
dc.subjectInfliximab
dc.subjectPopulation
dc.subjectMEDLINE
dc.subjectSystematic review
dc.titleUpdate of the PANCCO clinical practice guidelines for the treatment of ulcerative colitis in the adult population
dc.typereview

Files